|
Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery
RECRUITINGPhase 2Sponsored by Centre Francois Baclesse
Actively Recruiting
PhasePhase 2
SponsorCentre Francois Baclesse
Started2024-03-15
Est. completion2027-12
Eligibility
Age65 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06201884
Summary
The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.
Eligibility
Age: 65 Years+Healthy volunteers accepted
Inclusion Criteria: * Men or women aged 65 or over * Candidate for scheduled major oncological surgery and/or surgery with high morbidity * Patient able to walk for 10 minutes on the walking platform at the time of the test * Patient affiliated to a social security system * Signature of informed consent prior to any specific study-related procedure Exclusion Criteria: * Patient with severe undernutrition (BMI\<18, and/or weight loss \>15% in 6 months or \>10% in 1 month) * Emergency surgery * Physical contraindications preventing use of the platform * Simultaneous participation in another clinical study that could compromise the conduct of this study * Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent. * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Conditions4
CancerElderly PatientsOncologySurgery
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorCentre Francois Baclesse
Started2024-03-15
Est. completion2027-12
Eligibility
Age65 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06201884